Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mitigating the Pro-inflammatory Phenotype of Obesity

NCT04934228 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT04934228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04934228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mitigating the Pro-inflammatory Phenotype of Obesity
Lead sponsor
University of Kansas Medical Center
Phase
Phase 1
Overall status
Recruiting
Start date
July 1, 2021
Completion date
August 1, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, diabetes, diuretics drug reactions, insulin resistance, obesity, sympathetic nerve activity